Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma

This billing and coding guideline specifies claim submission requirements for MolDX molecular biomarker testing for cutaneous squamous cell carcinoma, including selection of the appropriate CPT and ICD-10-CM codes. Claims must report exactly 1 unit of service and include the appropriate DEX Z-Code adjacent to the CPT code in the specified Part A and Part B fields (with no extra characters on SV101-7).

"When entering the DEX Z-Code on the SV101-7 field for Part B claims, do not add additional characters or other information on that line."

Sign up to see full coverage criteria, indications, and limitations.